Jiangsu Yuyue Medical Equipment & Supply (002223) Q3 2025 earnings summary

Executive summary

• Revenue for Q3 2025 increased by 9.63% year-over-year to ¥1.89 billion, with year-to-date revenue up 8.58% to ¥6.54 billion.

• Net profit attributable to shareholders fell 35.99% year-over-year for the quarter and 4.28% year-to-date.

• Adjusted net profit (excluding non-recurring items) declined 17.50% for the quarter and 8.21% year-to-date.

• Cash flow from operating activities rose 8.77% year-over-year to ¥1.50 billion for the quarter.

Financial highlights

• Basic and diluted EPS for Q3 dropped 36.13% year-over-year; year-to-date EPS down 4.47%.

• Gross margin and operating profit margin not explicitly stated, but operating income and net income both declined.

• Total assets increased 6.55% to ¥16.67 billion; equity attributable to shareholders rose 7.86% to ¥13.52 billion.

Outlook and guidance

• No explicit forward-looking guidance provided, but management notes increased sales scale and ongoing strategic investments.